Usage Examples
Filter by Meaning The myeloblast is a precursor cell to the neutrophil.
The chemotherapy treatment had a significant impact on the patient's myeloblast count.
The patient's low myeloblast count indicated a compromised immune system.
The presence of myeloblast in his bone marrow indicates leukemia.
The myeloblast count in the patient's blood test was abnormally high.
The patient's myeloblast count was found to be abnormally high during the blood test.
The myeloblast cells originate from hematopoietic stem cells in the bone marrow.
The myeloblast cells are responsible for producing neutrophils and basophils.
The myeloblast count was elevated in the patient's peripheral blood smear.
The myeloblast population can expand rapidly in response to certain types of leukemia.
The myeloblast count in the patient's blood work indicated acute myeloid leukemia.
The myeloblast cells differentiate into myelocytes which produce white blood cells.
The high myeloblast count in the patient's blood was indicative of an aggressive form of leukemia.
The myeloblast count is one of the parameters used to diagnose leukemia.
The patient's myeloblast count indicated that he might have leukemia.
A myeloblast is an important precursor to the development of granulocytes.
The patient's myeloblast count was higher than expected, indicating the possibility of bone marrow cancer.
The myeloblast stage is considered the earliest stage in the development of granulocytes.
The myeloblast count in his bone marrow was extremely high.
The myeloblast count is often monitored during cancer treatment.
The patient's myeloblast count decreased after receiving treatment for acute myeloid leukemia.
The bone marrow transplant helped restore the patient's myeloblast population.
The myeloblast population can be identified and isolated through flow cytometry analysis.
The myeloblast cells were observed under the microscope to determine their level of differentiation.
The study aimed to investigate the correlation between myeloblast count and overall survival in leukemia patients.
Infections can cause an increase in myeloblast production in the body.
The researchers discovered a mutation in the gene responsible for myeloblast development.
The myeloblast count in the peripheral blood is higher than normal in patients with severe infections.
In acute lymphoblastic leukemia, the myeloblast count is usually low.
The patient's myeloblast count was abnormally high, indicating a possible infection.
The myeloblast count in the patient's blood sample was within the normal range.
The genetic mutations can affect the differentiation of myeloblast cells.
The chemotherapy aims to destroy the rapidly dividing myeloblast cells.
A myeloblast can develop into a mature granulocyte, monocyte, or lymphocyte.
The myeloblast stage is the earliest recognizable precursor to a white blood cell.
The myeloblast count is a critical parameter in the diagnosis and monitoring of myeloproliferative disorders.
The pathologist observed abnormal myeloblast morphology in the bone marrow biopsy.
The patient's myeloblast count decreased after receiving chemotherapy.
The myeloblast count in the bone marrow can be used to monitor disease progression.
The myeloblast count in the bone marrow biopsy report was higher than normal.
The myeloblast stage occurs in the bone marrow, and then the cells migrate to the bloodstream.
The patient's myeloblast count was within the normal range.
The myeloblast count in a blood test can provide valuable diagnostic information.
The myeloblast is a precursor of both neutrophils and basophils.
The myeloblast count was higher in the patient's blood than in the control group.
The patient's myeloblast count was abnormal, indicating a possible leukemia diagnosis.
Post a Comment